Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from China Traditional Chinese Medicine Holdings Co ( (HK:0570) ).
China Traditional Chinese Medicine Holdings Co. Limited announced a change in its board committee composition, with Mr. Liu Haijian being re-designated as a member of the Remuneration and Evaluation Committee, effective November 26, 2025. This strategic move is expected to enhance the company’s corporate governance by aligning its remuneration system with long-term performance goals and shareholder value growth, thereby improving decision-making quality and management precision.
The most recent analyst rating on (HK:0570) stock is a Sell with a HK$1.60 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited is a company incorporated in Hong Kong, focusing on the traditional Chinese medicine industry. It provides a range of products and services related to traditional Chinese medicine, catering to the healthcare market.
Average Trading Volume: 38,918,785
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.63B
Learn more about 0570 stock on TipRanks’ Stock Analysis page.